HAART Annuloplasty Device Valve Repair Registry

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

183 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-09-22

Study Completion Date

2024-07-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Multicenter US registry study to assess procedure success and long-term (10-year) performance of the HAART 200 and HAART 300 Aortic Annuloplasty Devices when used during aortic valve repair in a routine cardiovascular practice setting.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

HAART 200 Aortic Valve Annuloplasty Trial

NCT02071849

Aortic Insufficiency

COMPLETED NA

HAART Model 300 Annuloplasty Ring

NCT01400841

Aortic Regurgitation

COMPLETED NA

First in Human Feasibility Study With ADAPT 3D - ALR for Aortic Leaflet Repair

NCT04178213

Aortic Stenosis Aortic Insufficiency

UNKNOWN NA

Aortic Root Enlargement in Aortic Valve Replacement

NCT03603483

Aortic Valve Replacement

UNKNOWN NA

Early Feasibility Study for the Foldax Tria Aortic Heart Valve

NCT03851068

Aortic Valve Disease Aortic Valve Stenosis

ACTIVE_NOT_RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The HAART Aortic Annuloplasty Devices are three-dimensional annuloplasty rings designed to be implanted intra-annularly in the aortic valve to correct annular dilatation and/or maintain annular geometry of the aortic valve in patients with trileaflet valve morphology (HAART 300) or bicuspid valve morphology (HAART 200) with moderate to severe aortic insufficiency who are undergoing aortic valve repair due to symptoms or as part of a repair for an aortic aneurysm.

The study is a multicenter registry study enrolling both retrospective and prospective participants. Investigators are cardiothoracic surgeons specializing in surgery of the aortic valve and aorta at facilities with suitable infrastructure to support collection of the registry study data. Patients who underwent or will undergo aortic valve repair using either the HAART 300 or HAART 200 Device will be enrolled. All patients known to have received the HAART 300 or HAART 200 Device at participating centers will be contacted and offered the opportunity to enroll in this registry study. Prospective participants will have evaluations prior to surgery, intraoperatively, immediately following surgery, at discharge (or within 90 days), and at 1, 3, 5, and 10 years. In addition to the follow-up clinic visits, phone contacts are scheduled at years 2,4,6, 7, 8, and 9 to maintain participant engagement as well as to ascertain if any safety events have taken place. Retrospective participants who have already received the HAART 300 or HAART 200 Device prior to study enrollment will undergo safety assessment at the time of enrollment in the study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Aortic Valve Insufficiency Aortic Aneurysm

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

HAART 300

HAART 300 Aortic Annuloplasty Device

Aortic valve repair

Intervention Type DEVICE

Use of a HAART Aortic Annuloplasty Device in patients undergoing aortic valve repair surgery

HAART 200

HAART 200 Aortic Annuloplasty Device

Aortic valve repair

Intervention Type DEVICE

Use of a HAART Aortic Annuloplasty Device in patients undergoing aortic valve repair surgery

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Aortic valve repair

Use of a HAART Aortic Annuloplasty Device in patients undergoing aortic valve repair surgery

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* The patient underwent or is undergoing aortic valve repair using either the HAART 300 or HAART 200 Aortic Annuloplasty Device in accordance with the Instructions for Use.
* The patient has reviewed and signed the written informed consent form.
* The patient agrees to return for all follow-up evaluations for the duration of the study.